behavior/neurological
• 12-week-old mice show a reduction in grip strength
• treatment with an allele-specific RNAi results in improvement in grip strength
|
growth/size/body
• 12-wek-old mice show a reduction in body weight
• treatment with an allele-specific RNAi results in increased body weight
|
muscle
• 9-week-old late-symptomatic mice show muscle atrophy acceleration
|
nervous system
• the motor branch of the femoral nerve shows a decrease in axon number and axon diameter
• the sensory branch of the femoral nerve shows reduced axon diameters, however the number of myelinated axons is unchanged
|
• treatment with an allele-specific RNAi results in an increase in NMJ innervation
• distal muscles show disruption of neuromuscular junctions (NMJs)
• 60% of NMJs are partially occupied and 8.5% are completely denervated in plantaris muscle
• NJM innervation defects are evident at 6 weeks of age
|
• 5-week-old early-symptomatic mice undergo active axon loss
• axon loss slows down in 9-week-old late-symptomatic mice
• treatment with an allele-specific RNAi prevents axon loss
|
• nerve conduction velocities are reduced by 62% in the sciatic nerve
• treatment with an allele-specific RNAi results in improved sciatic nerve conduction velocity
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Charcot-Marie-Tooth disease type 2D | DOID:0110164 |
OMIM:601472 |
J:284948 |